Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-12 3:07 pm Sale | 2026-03-31 | 13G | CONTEXT THERAPEUTICS INC CNTX | Avidity Partners Management LP | 8,302,808 8.700% | -897,772 (-9.76%) | Filing History |
| 2026-04-17 10:13 am Purchase | 2026-02-17 | 13G | IMMUNIC INC IMUX | Avidity Partners Management LP | 1,395,841 9.900% | 925,900 (+197.02%) | Filing History |
| 2026-03-10 8:36 pm Purchase | 2026-02-20 | 13G | PERSPECTIVE THERAPEUTICS INC C CATX | Avidity Partners Management LP | 6,049,999 5.300% | 3,208,975 (+112.95%) | Filing History |
| 2026-02-17 10:19 am Sale | 2025-12-31 | 13G | SCYNEXIS INC SCYX | Avidity Partners Management LP | 553,321 9.900% | -11,274 (-2.00%) | Filing History |
| 2025-11-19 9:15 pm Sale | 2025-11-17 | 13D | DIANTHUS THERAPEUTICS INC DNTH | Avidity Partners Management LP | 2,104,184 4.900% | -1,274,755 (-37.73%) | Filing History |
| 2025-11-14 4:27 pm Purchase | 2025-09-30 | 13G | CONTEXT THERAPEUTICS INC CNTX | Avidity Partners Management LP | 9,200,580 9.900% | 74,404 (+0.82%) | Filing History |
| 2025-11-14 2:27 pm Purchase | 2025-09-30 | 13G | SCYNEXIS INC SCYX | Avidity Partners Management LP | 564,595 9.900% | 38,111 (+7.24%) | Filing History |
| 2025-11-14 1:39 pm Sale | 2025-09-30 | 13G | IMMUNIC INC IMUX | Avidity Partners Management LP | 469,941 4.800% | -91,640 (-16.32%) | Filing History |
| 2025-11-14 1:33 pm Sale | 2025-09-30 | 13G | KEZAR LIFE SCIENCES INC NE KZR | Avidity Partners Management LP | 0 0.000% | -502,600 (Position Closed) | Filing History |
| 2025-08-14 2:37 pm Sale | 2025-06-30 | 13G | IMMUNIC INC IMUX | Avidity Partners Management LP | 561,581 5.900% | -42,525 (-7.04%) | Filing History |
| 2025-08-14 2:28 pm Purchase | 2025-06-30 | 13G | CONTEXT THERAPEUTICS INC CNTX | Avidity Partners Management LP | 9,126,176 9.900% | 1,349,880 (+17.36%) | Filing History |
| 2025-05-15 2:07 pm Sale | 2025-03-31 | 13G | IMMUNIC INC IMUX | Avidity Partners Management LP | 604,106 6.600% | -298,130 (-33.04%) | Filing History |
| 2025-03-19 9:30 pm Purchase | 2025-03-17 | 13D | DIANTHUS THERAPEUTICS INC DNTH | Avidity Partners Management LP | 3,378,939 9.900% | 448,689 (+15.31%) | Filing History |
| 2025-02-14 10:42 am Purchase | 2024-12-31 | 13G | KEZAR LIFE SCIENCES INC KZR | Avidity Partners Management LP | 502,600 6.900% | 55 (+0.01%) | Filing History |
| 2025-02-14 10:26 am Sale | 2024-12-31 | 13G | PERSPECTIVE THERAPEUTICS INC C CATX | Avidity Partners Management LP | 2,841,024 4.200% | -749,402 (-20.87%) | Filing History |
| 2025-02-14 10:21 am Purchase | 2024-12-31 | 13G | SCYNEXIS INC SCYX | Avidity Partners Management LP | 526,484 9.900% | 4,334 (+0.83%) | Filing History |
| 2025-02-14 10:16 am Purchase | 2024-12-31 | 13G | IMMUNIC INC IMUX | Avidity Partners Management LP | 902,236 9.900% | 3,292 (+0.37%) | Filing History |
| 2025-02-14 10:10 am Sale | 2024-12-31 | 13G | SYROS PHARMACEUTICALS INC SYRS | Avidity Partners Management LP | 2,048,020 7.600% | -809,553 (-28.33%) | Filing History |
| 2025-02-14 10:02 am Unchanged | 2024-12-31 | 13G | CONTEXT THERAPEUTICS INC CNTX | Avidity Partners Management LP | 7,776,296 9.900% | 0 (Unchanged) | Filing History |
| 2024-12-03 9:19 pm Purchase | 2024-11-29 | 13D | DIANTHUS THERAPEUTICS INC DNTH | Avidity Partners Management LP | 2,930,250 9.900% | 7,427 (+0.25%) | Filing History |